361 results
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona
Author
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
29 Aug 2022
The above guideline was published during the 2022 ESC Congress in Barcelona and was chaired by Professor Julinda Mehilli (Germany) and Professor Sigrun Halvorsen (Norway). This guideline was developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society...
Author
ISCHEMIA-CKD EXTEND: revascularization does not improve outcomes at 5 years in patients with advanced chronic kidney disease
29 Aug 2022
Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results - clinical outcomes at 5 years of follow-up, which were presented during the ESC 2022 congress in Barcelona.
Author
Association of medication adherence with health outcomes in the ISCHEMIA Trial
26 Aug 2022
This sub-analysis of ISCHEMIA has shown that implementation of a simple protocol of optimal medical therapy is a key factor to improve health outcome and practical in real-world settings.
Reviewer
Reviewer
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
25 Aug 2022
In this post-hoc analysis of the TWILIGHT trial, the authors report the effects of ticagrelor monotherapy compared to ticagrelor and aspirin in patients with prior CABG at least three months post PCI with no adverse events and at least one clinical and one angiographic high-risk feature...
Reviewer
FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial
24 Aug 2022
The primary objective of the study was to assess whether an IVUS-based stent optimization provided an incremental value in terms of vessel-related adverse event occurrence in patients presenting with low post-PCI FFR (<0.90).
Reviewer
Reviewer
How can physiology guide you in non LM bifurcation PCI?
18 Dec 2019
View the replay of this webinar on physiology with Jens Flensted Lassen, Lisette Okkels Jensen, Thomas Engstroem and Anders Junker
How physiology can guide you in LM PCI?
05 Nov 2019
View this replay of a LIVE Webinar - How physiology can guide you in LM PCI? With Jose M De La Torre Hernandez, Flavio Ribichini and Dae-Hyun Lee Hwang
How the QFR in your cathlab can help us to assess non-invasively the coronary physiology?
27 Oct 2021
Discover the replay of this PCR Webinar on coronary physiology with M. Gilard, H. D. Mejía-Rentería and D. Leistner
Closing the loop of coronary physiology: from FFR to microvascular resistance reserve (MRR)
14 Dec 2021
Watch the replay of this PCR Webinar on coronary physiology with J. Escaned , C. Berry, B. De Bruyne and N. HJ Pijls
